Drug Utilization Study for Olodaterol
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2019
Price : $35 *
At a glance
- Drugs Olodaterol (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 09 Apr 2018 Status changed from active, no longer recruiting to completed.
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.